Don't forget COVID and the exigency of the circumstances surrounding the pandemic.
I cannot see India, Brazil, etc., refusing some kind of emergency authorisation for treatment to its citizens. Or governments NOT agreeing to fund trials for COVID ARDS patients like the NIH did in the US - where all MSB had to supply was the cells. The results from the COVID ARDS trials would, I imagine, be good fodder for discussions on similar trials in other countries...with all of the results further supporting the proof of Rem-L's efficacy (particularly in conjunction with Dexamethasone) and safety. Does any of us really think that some of these countries in such dire straits would refuse to arrange similar trials to the ones funded by the NIH?
We can make all the excuses for management that we would like...but they are clearly missing opportunities, and if they have a plan that covers more than the US, they sure haven't shared it with us...
- Forums
- ASX - By Stock
- MSB Trading 2021 - paradigm shift
Don't forget COVID and the exigency of the circumstances...
-
- There are more pages in this discussion • 2,489 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
0.028(1.85%) |
Mkt cap ! $1.741B |
Open | High | Low | Value | Volume |
$1.57 | $1.58 | $1.41 | $15.89M | 10.59M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 66822 | $1.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.52 | 32219 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 9515 | 1.520 |
14 | 109170 | 1.515 |
9 | 122572 | 1.510 |
9 | 63871 | 1.505 |
7 | 69634 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.525 | 38505 | 11 |
1.530 | 46949 | 12 |
1.535 | 177485 | 5 |
1.540 | 137348 | 14 |
1.545 | 117028 | 8 |
Last trade - 15.13pm 07/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |